[en] Glycoprotein VI (GPVI) has a crucial role in platelet responses to collagen. Still, little is known about its interaction with its ligands. In binding assays using soluble or cell-expressed human GPVI, we observed that (i) collagen, and the GPVI-specific ligands collagen-related peptides (CRP) and convulxin, competed with one another for the binding to GPVI and (ii) monoclonal antibodies directed against the extracellular part of the human receptor displayed selective inhibitory properties on GPVI interaction with its ligands. Monoclonal antibody 9E18 strongly reduced the binding of GPVI to collagen/CRP, 3F8 inhibited its interaction with convulxin, whereas 9O12 prevented all three interactions. These observations suggest that ligand-binding sites are distinct, exhibiting specific features but at the same time also sharing some common residues participating in the recognition of these ligands. The epitope of 9O12 was mapped by phage display, along with molecular modeling of human GPVI, which allowed the identification of residues within GPVI potentially involved in ligand recognition. Site-directed mutagenesis revealed that valine 34 and leucine 36 are critical for GPVI interaction with collagen and CRP. The loop might thus be part of a collagen/CRP-binding site.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Lecut, Christelle ; Institut National de la Santé et de la Recherche Médicale - INSERM > E348, Faculté de Médecine Xavier Bichat, Université Paris 7, France
Arocas, Veronique
Ulrichts, Hans
Elbaz, Anthony
Villeval, Jean-Luc
Lacapere, Jean-Jacques
Deckmyn, Hans
Jandrot-Perrus, Martine
Language :
English
Title :
Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites.
Publication date :
2004
Journal title :
Journal of Biological Chemistry
ISSN :
0021-9258
eISSN :
1083-351X
Publisher :
American Society for Biochemistry and Molecular Biology, Baltimore, United States - Maryland
Clemetson, K. J., and Clemetson, J. M. (2001) Thromb. Haemostasis 86, 189-197
Clemetson, J. M., Polgar, J., Magnenat, E., Wells, T. N., and Clemetson, K. J. (1999) J. Biol. Chem. 274, 29019-29024
Jandrot-Perrus, M., Busfield, S., Lagrue, A. H., Xiong, X., Debili, N., Chickering, T., Le Couedic, J. P., Goodearl, A., Dussault, B., Fraser, C., Vainchenker, W., and Villeval, J. L. (2000) Blood 96, 1798-1807
Gibbins, J. M., Okuma, M., Faradale, R., Barnes, M., and Watson, S. P. (1997) FBBS Lett. 413, 255-259
Asselin, J., Gibbins, J. M., Achison, M., Lee, Y. H., Morton, L. F., Farndale, R. W., Barnes, M. J., and Watson, S. P. (1997) Blood 89, 1235-1242
Francischetti, I. M., Saliou, B., Leduc, M., Carlini, C. R., Hatmi, M., Randon, J., Faili, A., and Bon, C. (1997) Toxicon 35, 1217-1228
Jandrot-Perrus, M., Lagrue, A. H., Okuma, M., and Bon, C. (1997) J. Biol. Chem. 272, 27035-27041
Watson, S. P., Asazuma, N., Atkinson, B., Berlanga, O., Best, D., Bobe, R., Jarvis, G., Marshall, S., Snell, D., Stafford, M., Tulasne, D., Wilde, J., Wonerow, P., and Frampton, J. (2001) Thromb. Haemostasis 86, 276-288
Moroi, M., Jung, S. M., Okuma, M., and Shinmyozu, K. (1989) J. Clin. Investig. 84, 1440-1445
Kehrel, B., Wierwille, S., Clemetson, K. J., Anders, O., Steiner, M., Knight, C. G., Farndale, R. W., Okuma, M., and Barnes, M. J. (1998) Blood 91, 491-499
Heemskerk, J. W., Siljander, P., Vuist, W. M., Breikers, G., Reutelingsperger, C. P., Barnes, M. J., Knight, C. G., Lassila, R., and Farndale, R. W. (1999) Thromb. Haemostasis 81, 782-792
Nieswandt, B., Brakebusch, C., Bergmeier, W., Schulte, V., Bouvard, D., Mokhtari-Nejad, R., Lindhout, T., Heemskerk, J. W., Zirngibl, H., and Fassler, R. (2001) EMBO J. 20, 2120-2130
Martin, A. M., Kulski, J. K., Witt, C., Pontarotti, P., and Christiansen, F. T. (2002) Trends Immunol. 23, 81-88
Wines, B.D., Sardjono, C. T., Trist, H. H., Lay, C. S., and Hogarth, P. M. (2001) J. Immunol. 166, 1781-1789
Fan, Q. R., Long, E. O., and Wiley, D. C. (2001) Nat. Immunol. 2, 452-460
Hulett, M. D., McKenzie, I. F., and Hogarth, P. M. (1993) Eur. J. Immunol. 23, 640-645
Lecut, C., Feeney, L. A., Kingsbury, G., Hopkins, J., Lanza, F., Gachet, C., Villeval, J. L., and Jandrot-Perrus, M. (2003) J. Thromb. Haemost. 1, 2653-2662
Morton, L. F., Hargreaves, P. G., Farndale, R. W., Young, R. D., and Barnes, M. J. (1995) Biochem. J. 306, 337-344
Vanhoorelbeke, K., Depraetere, H., Romijn, R. A., Huizinga, E. G., De Maeyer, M., and Deckmyn, H. (2003) J. Biol. Chem. 278, 37815-37821
Ulrichts, H., Depraetere, H., Harsfalvi, J., and Deckmyn, H. (2001) Thromb. Haemostasis 86, 630-635
Lagrue-Lak-Hal, A. H., Debili, N., Kingbury, G., Lecut, C., Le Couedic, J. P., Villeval, J. L., Jandrot-Perrus, M., and Vainchenker, W. (2001) J. Biol. Chem. 276, 15316-15325
Chapman, T. L., Heikema, A. P., West, A. P., Jr., and Bjorkman, P. J. (2000) Immunity 13, 727-736
Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680
Sali, A., and Blundell, T. L. (1993) J. Mol. Biol. 234, 779-815
Nieswandt, B., and Watson, S. P. (2003) Blood 102, 449-461
Schulte, V., Snell, D., Bergmeier, W., Zirngibl, H., Watson, S. P., and Nieswandt, B. (2001) J. Biol. Chem. 276, 364-368
Siljander, P. R., Munnix, I. C., Smethurst, P. A., Deckmyn, H., Lindhout, T., Ouwehand, W. H., Farndale, R. W., and Heemskerk, J. W. (2003) Blood
Smethurst, P. A., Joutsi-Korhonen, L., O'Connor, M. N., Wilson, E., Jennings, N. S., Garner, S. F., Zhang, Y., Knight, C. G., Dafforn, T. R., Buckle, A., Ijsseldijk, M. J., De Groot, P. G., Watkins, N. A., Farndale, R. W., and Ouwehand, W. H. (2003) Blood